miR-2392 serves as an immunological and prognostic biomarker in hepatocellular carcinoma

Liver Int. 2022 Dec;42(12):2923-2924. doi: 10.1111/liv.15393. Epub 2022 Oct 19.

Authors

Huizi Li¹, Fei Cheng¹, Xingyao Su¹, Shengxun Mao¹

Affiliation

¹ Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China.

PMID: 35962781
DOI: 10.1111/liv.15393

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers, Tumor / genetics
Carcinoma, Hepatocellular* / genetics
Carcinoma, Hepatocellular* / pathology
Gene Expression Regulation, Neoplastic
Humans
Liver Neoplasms* / genetics
Liver Neoplasms* / pathology
MicroRNAs* / genetics
Prognosis

Substances

MicroRNAs
Biomarkers, Tumor